Covered recipient · General Payments record
MICHAEL HOUSER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,623.47
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $436.73 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $134.19 | 1 |
| Novo Nordisk AS | $92.64 | 5 |
| PFIZER INC. | $64.29 | 4 |
| ABBVIE INC. | $53.71 | 2 |
| Astellas Pharma US Inc | $21.77 | 1 |
| Amgen Inc. | $20.53 | 1 |
| Abbott Laboratories | $16.83 | 1 |
| Exact Sciences Corporation | $16.53 | 1 |
| Phadia US Inc. | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.83 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124958586 | CMS |
| ABBVIE INC. | $32.14 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103942733 | CMS |
| ABBVIE INC. | $21.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103942735 | CMS |
| Amgen Inc. | $20.53 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115734472 | CMS |
| Astellas Pharma US Inc | $21.77 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139402489 | CMS |
| AstraZeneca Pharmaceuticals LP | $134.19 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104637953 | CMS |
| Exact Sciences Corporation | $16.53 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114708402 | CMS |
| Novo Nordisk Inc | $16.18 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097551353 | CMS |
| Novo Nordisk Inc | $16.53 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097062742 | CMS |
| Novo Nordisk Inc | $18.93 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888350 | CMS |
| Novo Nordisk Inc | $17.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097757609 | CMS |
| Novo Nordisk Inc | $23.06 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902733 | CMS |
| PFIZER INC. | $14.05 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131045976 | CMS |
| PFIZER INC. | $15.49 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131711271 | CMS |
| PFIZER INC. | $15.35 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131639152 | CMS |
| PFIZER INC. | $19.40 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132076175 | CMS |
| Phadia US Inc. | $16.24 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067583594 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.